The Los Angeles Post
U.S. World Business Lifestyle
Today: April 11, 2025
Today: April 11, 2025

Pfizer, BioNTech shares fall on COVID product sales uncertainty

FILE PHOTO: COVID-19 vaccination at the Institute for Health and Food Safety of Zenica
April 26, 2024
Ludwig Burger - Reuters

By Ludwig Burger

(Reuters) - Shares of Pfizer and German partner BioNTech fell on Monday after the U.S. drugmaker slashed the sales forecast for its COVID vaccine and therapy last week, and some analysts said the reduction was bigger than expectations.

Hit by a plunge in the use of pandemic-related products, Pfizer on Friday reduced its full-year forecast for sales of its antiviral COVID treatment Paxlovid by about $7 billion, and for the vaccine it developed with BioNTech by about $2 billion.

Pfizer said it will take a non-cash charge of $5.5 billion in the third quarter due to $4.6 billion in inventory write-offs for Paxlovid and $900 million of write-offs for the vaccine, while BioNTech flagged write-downs of up to 900 million euros ($947 million).

The COVID sales forecast cut was bigger than expected, Wells Fargo analyst Mohit Bansal said, adding that Wall Street's COVID sales estimates for the next few years may come down.

Shares in BioNTech, which is also developing cancer treatments, were down 6.7% at 0904 GMT, at a two-month low in Frankfurt. Its U.S.-listed shares fell 5% in premarket trading, while Pfizer's shares fell 3.5%.

The news also dragged down shares of rival COVID vaccine maker Moderna by 3.8%.

BioNTech, which relies on vaccine-related profit-sharing payments from Pfizer for much of its revenue, said the write-offs would also reduce its 2023 revenue.

A BioNTech spokesperson on Monday declined to comment on the company's current 2023 outlook.

The company added that it had been told by Pfizer that most of the write-offs relate to raw materials, as well as to inventories of vaccine versions that are older or different from the upgraded one currently in use.

Pfizer's shares, which are down about 37% this year, trade 9.8 times their 12-month forward earnings estimate, while BioNTech trades at 26.7, according to LSEG data.

($1 = 0.9498 euros)

(Reporting by Ludwig Burger and Rachel More in Frankfurt and Manas Mishra in Bengaluru; Editing by Miranda Murray, Jason Neely and Shounak Dasgupta)

Related Articles

Pfizer CEO defends turnaround strategy as activist pressures management Pfizer management looks to show turnaround as Starboard looms Spanish drugmaker Rovi to keep third-party manufacturing business Starboard Value CEO says Pfizer's board should hold management accountable
Share This

Popular

Business|Economy|Political|Technology|World

Kevin O'Leary says US has to train China 'like a puppy'

Kevin O'Leary says US has to train China 'like a puppy'
Business|Economy|Finance|Political|Stock Markets|US|World

The Latest: Trump administration offers no details on mistakenly deported man after court ruling

The Latest: Trump administration offers no details on mistakenly deported man after court ruling
Business|Economy|US

'The cup is empty': Glass plant shuts down Friday, ending over a century of production

'The cup is empty': Glass plant shuts down Friday, ending over a century of production
Business|Economy|Finance|Political|Stock Markets

Trump has 90 days to do 150 trade deals. Financial markets arenโ€™t buying it

Trump has 90 days to do 150 trade deals. Financial markets arenโ€™t buying it

Health

Education|Health|Lifestyle|US

2-year-old 'genius' on autism spectrum shows us how kids like him can excel with the right care

2-year-old 'genius' on autism spectrum shows us how kids like him can excel with the right care
Americas|Celebrity|Entertainment|Health|Political|Sports|World

What we know about the Dominican nightclub collapse and its victims

What we know about the Dominican nightclub collapse and its victims
Health|Lifestyle|Science

What is the salt trick for men, and is it a secret to improved intimacy?

What is the salt trick for men, and is it a secret to improved intimacy?
Fashion and Beauty|Health|Lifestyle|Science

Women report more hair loss than men at every ageโ€”is stress at play?

Women report more hair loss than men at every ageโ€”is stress at play?

Access this article for free.

Already have an account? Sign In